In today’s briefing:
- Merger Arb Mondays (03 Nov) – ANE, Dongfeng, Mayne, AUB, Digital Holdings, Makino, Soft99, SCSK
- China Healthcare Weekly (Nov.2) – 11th National VBP, More BD Deal to Come, WuXi AppTec 25Q3 Results
- Qfin Holdings Inc.(QFIN): Buying on Pullbacks Still Makes Sense Here
- HK CEO/Director Dealings (31 Oct 2025): Shanghai Chicmax, AuGroup (Shenzhen), Twintek, Rongzun
- Chery (9973 HK): 3Q25, Revenue Growth Plunged to Single Digit
- (Mostly) Asia M&A, Oct 2025 Wrap: Hang Seng, SCSK, AUB, Sumitomo Densetsu, Genting Malaysia, ANE
- Mininglamp Technology IPO Trading: Strong Retail Demand, Decent Insti Demand
- Pre-IPO Softcare (PHIP Updates) – Some Points Worth the Attention
- Macro Monthly (November): Rising Volatility, Positive Seasonals and a Concerning Trend
- Primer: Dongfeng Electronic Tech A (600081 CH) – Nov 2025

Merger Arb Mondays (03 Nov) – ANE, Dongfeng, Mayne, AUB, Digital Holdings, Makino, Soft99, SCSK
- I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan, Indonesia, Malaysia, Philippines, Thailand and Chinese ADRs.
- Highest spreads: Mayne Pharma (MYX AU), Brainpad Inc (3655 JP), Smart Share Global (EM US), AUB Group Limited (AUB AU), ENN Energy (2688 HK), Dongfeng Motor (489 HK).
- Lowest spreads: Bright Smart Securities (1428 HK), Mandom Corp (4917 JP), Pacific Industrial (7250 JP), Seven West Media (SWM AU), Humm Group (HUM AU), Toyota Industries (6201 JP).
China Healthcare Weekly (Nov.2) – 11th National VBP, More BD Deal to Come, WuXi AppTec 25Q3 Results
- The 11th national VBP officially started last week. The average price reduction of the selected products is 53%. Due to the “anchor price” mechanism, VBP is becoming increasingly rational.
- The purchasing power of the global pharmaceutical industry on Chinese assets is still far from saturated that we have reason to expect more transactions to come to Chinese pharmaceutical companies.
- Based on WuXi AppTec’s 25Q3 results, CDMO business has emerged from fundamental turning point following the recovery of overseas biotech industry, but the inflection point of CRO is lagging behind.
Qfin Holdings Inc.(QFIN): Buying on Pullbacks Still Makes Sense Here
- QFIN shares are down ~19% MTD on regulatory concerns in China’s consumer finance sector, though the proposed credit-risk sharing rules may only modestly impact near-term RoE (1–3ppt).
- While speculation over a lower NFRA loan yield cap persists, QFIN’s current yield profile suggests limited sensitivity; any tangible financial impact will depend on actual regulation rollout.
- QFIN’s 0.9x P/B reflects overly bearish loss expectations. Even under a bear case with a 5ppt RoE reduction, the stock offers 56% upside, implying a fair value of $34.
HK CEO/Director Dealings (31 Oct 2025): Shanghai Chicmax, AuGroup (Shenzhen), Twintek, Rongzun
- The data in this insight is collated from the “shareholding disclosure” link on the HKEx website.
- Often there is a corresponding HKEx announcement on the increase – or decrease – in the shareholding by directors.
- However, such disclosures are by no means an absolute. These insights also flag those companies where shares have been pledged, both recently and ongoing.
Chery (9973 HK): 3Q25, Revenue Growth Plunged to Single Digit
- Chery’s revenue growth rate plunged below 5% YoY in 3Q25 from 28% YoY in 2Q25.
- Chery’s domestic retail sales volume began to decline in September 2025.
- The company is still the number five largest car maker in China.
(Mostly) Asia M&A, Oct 2025 Wrap: Hang Seng, SCSK, AUB, Sumitomo Densetsu, Genting Malaysia, ANE
- For Oct 2025, 15 new transactions (firm and non-binding) were discussed on Smartkarma (by the Quiddity team) with an overall announced deal size of ~US$33bn.
- The average premium for the new transactions announced (or first discussed) in October was ~54%, with a year-to-date average of ~49%.
- The average premiums for transactions in 2024 (129 transactions), 2023 (117), 2022 (106), 2021 (165), 2020 (158), and 2019 (145 ) were 43%, 39%, 41%, 33%, 31%, and 31%.
Mininglamp Technology IPO Trading: Strong Retail Demand, Decent Insti Demand
- Mininglamp Technology (1912140D HK) raised around US$131m in its Hong Kong IPO.
- Mininglamp Technology (formerly known as Leading Smart Holdings), is a data intelligence software provider in China, specializing in transforming enterprises’ marketing and operational decision-making.
- We have looked at the company’s background and pricing in our earlier note, in this note we talk about the trading dynamics.
Pre-IPO Softcare (PHIP Updates) – Some Points Worth the Attention
- The rise of Softcare is in line with the logic of “Chinese supply chain going global”.It has solved channel/cost problems through localized production, quickly captured market share with low-price tactic.
- Our forecast benefiting from market penetration/capacity expansion, revenue growth could be 15% YoY in 2025.In 2026-2027, as competition intensifies, revenue growth may slow down to 12% YoY, 10% YoY respectively.
- Given that Softcare’s main market is in Africa, which is characterized by high growth and high risk, a forecasted P/E of 8-12x for 2025 could be a comfortable valuation range.
Macro Monthly (November): Rising Volatility, Positive Seasonals and a Concerning Trend
- Implied volatility rose across most markets in October, and a continuing trend in vol premium warrants attention.
- November has historically produced strong price returns and positive volatility premiums across global markets.
- Implied volatility displays clustering across markets, with two distinct groupings beginning to take shape.
Primer: Dongfeng Electronic Tech A (600081 CH) – Nov 2025
- Dongfeng Electronic Technology (DETC) is a core automotive components supplier within the state-owned Dongfeng Motor Group, heavily reliant on intra-group sales. This relationship provides stable demand but also concentrates risk and limits exposure to the broader, faster-growing segments of the Chinese auto market.
- The company’s financial performance has been challenged, with multi-year declines in revenue, net income, and earnings per share. This reflects significant headwinds in the commercial vehicle sector and increasing competition, pressuring margins and profitability.
- While currently focused on traditional vehicle components, DETC’s future hinges on its ability to pivot towards the New Energy Vehicle (NEV) and intelligent vehicle segments. Strategic initiatives and R&D in areas like electric drive systems and smart cockpits are critical but face intense competition from established and emerging players.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.
